BioNote, Inc. (KRX:377740)

South Korea · Delayed Price · Currency is KRW

5,820.00

-10.00 (-0.17%)

Last updated: Feb 20, 2026, 2:39 PM KST

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Animal	71.82B	65.64B	67.30B	57.67B	-
Animal Growth	9.42%	-2.47%	16.70%	-	-
Life Science	30.96B	24.44B	416.25B	566.41B	-
Life Science Growth	26.67%	-94.13%	-26.51%	-	-
Inter-Segment Revenue	-	-	-3.90B	-1.73B	-
Diagnostic Kits / Equipment	-	-	-	-	631.50B
Diagnostic Kits / Equipment Growth	-	-	-	-	1476.89%
Total	102.78B	90.08B	479.66B	622.36B	631.50B
Total Growth	14.10%	-81.22%	-22.93%	-1.45%	1476.89%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
South Korea	37.86B	35.34B	390.07B	522.15B	533.63B
South Korea Growth	7.12%	-90.94%	-25.30%	-2.15%	2952.01%
Overseas	64.92B	54.74B	89.59B	100.21B	-
Overseas Growth	18.60%	-38.90%	-10.60%	-	-
America	-	-	-	-	5.87B
Africa	-	-	-	-	351.94M
Europe	-	-	-	-	14.80B
Asia	-	-	-	-	76.37B
Oceania	-	-	-	-	476.40M
Total	102.78B	90.08B	479.66B	622.36B	631.50B
Total Growth	14.10%	-81.22%	-22.93%	-1.45%	1476.89%

Source: S&P Global Market Intelligence.